These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 20015244

  • 21. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW, Defesche JC, Kastelein JJ, Sijbrands EJ.
    Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
    [Abstract] [Full Text] [Related]

  • 22. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
    Côté C, Pibarot P, Després JP, Mohty D, Cartier A, Arsenault BJ, Couture C, Mathieu P.
    Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S.
    Blood Purif; 2007 Sep; 25(5-6):457-65. PubMed ID: 18075247
    [Abstract] [Full Text] [Related]

  • 26. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis.
    Paterson RL, Galley HF, Webster NR.
    Crit Care Med; 2003 Nov; 31(11):2574-8. PubMed ID: 14605526
    [Abstract] [Full Text] [Related]

  • 27. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.
    Streicher J, Valent P, Schmidt H, Sengölge G, Wagner O, Strobl W, Hörl WH, Derfler K.
    J Investig Med; 1999 Sep; 47(8):378-87. PubMed ID: 10510590
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Auto-antibodies against oxidized LDL as a marker of coronary artery disease in patients with familial hypercholesterolaemia.
    Paiker JE, Raal FJ, von Arb M.
    Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():174-8. PubMed ID: 10735360
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia.
    Pirinccioglu AG, Gökalp D, Pirinccioglu M, Kizil G, Kizil M.
    Clin Biochem; 2010 Oct; 43(15):1220-4. PubMed ID: 20691171
    [Abstract] [Full Text] [Related]

  • 38. Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome.
    Jialal I, Devaraj S, Adams-Huet B, Chen X, Kaur H.
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1844-50. PubMed ID: 22872691
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. High plasma phospholipase A2 activity, inflammation markers, and LDL alterations in obesity with or without type 2 diabetes.
    Garces F, López F, Niño C, Fernandez A, Chacin L, Hurt-Camejo E, Camejo G, Apitz-Castro R.
    Obesity (Silver Spring); 2010 Oct; 18(10):2023-9. PubMed ID: 20134414
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.